YIH
TECX

Y-Intercept (HK)’s Tectonic Therapeutic TECX Stock Holding History

Y-Intercept (HK)’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,212
Closed -$234K – 2094
2025
Q1 		$234K Buy
+13,212
New +$431K 0.02% 1000

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Y-Intercept (HK)'s TECX Position: Q2 2025 in Review

Y-Intercept (HK) sold out of Tectonic Therapeutic (TECX) in Q2 2025, closing a stake of 13,212 shares — an estimated $234K sold.

Y-Intercept (HK) first reported a position in TECX in Q1 2025 and held it in 1 quarter. The position peaked at $234K in Q1 2025. 82 funds tracked by Wall St. Rank hold TECX as of Q2 2025.

  • Y-Intercept (HK) reported no remaining Tectonic Therapeutic position as of Q2 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 13,212 Tectonic Therapeutic shares in Q2 2025, an estimated $234K.
  • Y-Intercept (HK) first reported a position in Tectonic Therapeutic in Q1 2025 and held it in 1 quarter.
  • Y-Intercept (HK)'s Tectonic Therapeutic position peaked at $234K in Q1 2025.
  • 82 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2025.

Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.